These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12119561)

  • 1. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma.
    Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I
    Int J Mol Med; 2002 Aug; 10(2):211-6. PubMed ID: 12119561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
    Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.
    Ota T; Gilks CB; Longacre T; Leung PC; Auersperg N
    Reprod Sci; 2007 Sep; 14(6):605-14. PubMed ID: 17959889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of Elf-1 expression in epithelial ovarian carcinoma.
    Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I
    Int J Mol Med; 2003 Sep; 12(3):349-54. PubMed ID: 12883651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.
    Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
    Cohen C; Lohmann CM; Cotsonis G; Lawson D; Santoianni R
    Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proliferating cell nuclear antigen (PCNA) in ovarian carcinoma and its relation to lymph node metastasis and prognosis].
    Wu X; Zhang Z; Cai S
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):68-70. PubMed ID: 10921065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.
    Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M
    Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological classification of ovarian cancer.
    Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
    Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative activity and p53 over-expression of ovarian epithelial tumors.
    Kuwata T; Kitagawa M; Takemura T; Hirokawa K
    Gen Diagn Pathol; 1995 Oct; 141(2):131-9. PubMed ID: 8548593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining.
    Kritpracha K; Hanprasertpong J; Chandeying V; Dechsukhum C; Geater A
    J Obstet Gynaecol Res; 2005 Jun; 31(3):268-76. PubMed ID: 15916666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer.
    Sillanpää S; Anttila M; Suhonen K; Hämäläinen K; Turpeenniemi-Hujanen T; Puistola U; Tammi M; Sironen R; Saarikoski S; Kosma VM
    Tumour Biol; 2007; 28(5):280-9. PubMed ID: 17962725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].
    Hu YQ; Liu YJ
    Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancer.
    Brustmann H
    Pathol Res Pract; 2006; 202(10):713-20. PubMed ID: 16962250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of survivin and correlation with PCNA in osteosarcoma.
    Wang W; Luo H; Wang A
    J Surg Oncol; 2006 Jun; 93(7):578-84. PubMed ID: 16705726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of COX-2 and survivin expression in ovarian cancer.
    Athanassiadou P; Grapsa D; Athanassiades P; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
    Pathol Res Pract; 2008; 204(4):241-9. PubMed ID: 18171606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration and clinical relevance of PTEN expression and its correlation with survivin expression in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):773-8. PubMed ID: 16525657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.